The burden of "sticky" amyloid: Typing challenges

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 6, 2007, Pages 850-851

  Picken, Maria M ^a   Herrera, Guillermo A ^b  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID A PROTEIN;

AMYLOIDOSIS; EDITORIAL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY AMYLOIDOSIS; KIDNEY BIOPSY; PROTEIN ANALYSIS;

AMYLOID; AMYLOIDOSIS; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOHISTOCHEMISTRY;

EID: 34250158438     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Editorial

References (15)

1. Satoskar AA, Burdge K, Cowden DJ, Nadasdy GM, Hebert LA, Nadasdy T. Typing of amyloidosis in renal biopsies: diagnostic pitfalls. Arch Pathol Lab Med. 2007;131:917-922.
2. Novak L, Cook WJ, Herrera GA, et al. AL-amyloidosis is underdiagnosed in renal biopsies. Nephrol Dial Transplant. 2004;19:3050-3053.
3. Herrera GA, Picken MM. Renal diseases associated with plasma cell dyscrasias, amyloidoses, Waldenstrom macroglobulinemia and cryoglobulinemia nephropathies. In: Jennette JC, Olson JL, Schwartz MM, Silva FG, eds. Heptinstall's Pathology of the Kidney. 6th ed. Philadelphia, Pa: Lippincott, Williams & Wilkins; 2006:853-910.
4. Picken MM. Immunoglobulin light and heavy chain amyloid: renal pathology and differential diagnosis. Contrib Nephrol. 2007;153:135-155.
5. Kebbel A, Rocken C. Immunohistochemical classification of amyloid in surgical pathology revisited. Am J Surg Pathol. 2006;30:673-683.
6. Lachmann HJ, Booth DR, Booth SE, et al. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med. 2002;346:1786-1791.
7. Comenzo RL, Zhou P, Fleisher M, et al. Seeking confidence in the diagnosis of systemic AL (Ig light chain) amyloidosis: patients can have both monoclonal gammopathies and hereditary amyloid proteins. Blood. 2006;107:3489-3491.
8. Landau H, Comenzo RL, Zhou P, et al. AL amyloidosis in a patient with a T60A TTR mutation. Amyloid. 2006;13(suppl 1):40A.
9. Herrera GA, Sanders PW, Reddy et al. Ultrastructural immunolabeling: a unique diagnostic tool in monoclonal light chain related renal diseases. Ultrastruct Pathol. 1994;18:401-416.
10. Herrera GA. The contributions of electron microscopy to the understanding and diagnosis of plasma cell dyscrasia-related renal lesions. Med Electron Microsc. 2001;34:1-8.
11. Westermark P, Davey E, Lindbom K, Enquist S. Subcutaneous fat tissue for diagnosis and studies of systemic amyloidosis. Acta Histochem. 2006;108: 209-213.
12. Murphy CL, Wang S, Williams T, et al. Characterization of systemic amyloid deposits by mass spectrometry. Methods Enzymol. 2006;412:48-62.
13. Lavatelli F, Perlman DH, McComb ME, et al. A proteomic approach to the study of systemic amyloidoses. Amyloid. 2006;13(suppl 1):13A.
14. Nasr SH, Galgano SJ, Markowitz GS, et al. Immunofluorescence on pronase-digested paraffin sections: a valuable salvage techniques for renal biopsies. Kidney Int. 2006;70:2148-2151.
15. Bersgtrom J, Murphy CL, Weiss DT, et al. Two different types of amyloid deposits - apolipoprotein A-IV and transthyretin - in a patient with systemic amyloidosis. Lab Invest. 2004;84:981-988.